SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa™ Lymphoma test ...
The collaboration with Fox Chase and its Cancer Epigenetics Institute will help physicians better identify genomic changes that traditional testing methods may miss, thus improving diagnosis and ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians seeking to improve human health, ...
SAN DIEGO-- Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information towards the understanding of health, disease and species ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback